ストックスクリーナーアプリを入手
0.8404
3.26%
-0.0283
アフターアワーズ：
.85
0.0096
+1.14%
Fibrobiologics Inc (FBLG) 最新ニュース
FibroBiologics (FBLG) Completes Key Drug Batch for Clinical Tria - GuruFocus
FibroBiologics completes third batch of diabetic foot ulcer drug - Investing.com
FibroBiologics says one more batch should finish its diabetes foot ulcer trial - Stock Titan
FibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - BioSpace
FibroBiologics CEO, chief scientist join cell therapy conference chat - Stock Titan
FibroBiologics Secures Up to $9 Million in At-the-Market Private Placement to Advance Cell Therapy Pipeline 1 - Minichart
FibroBiologics closes $3M private placement with warrants - Investing.com UK
FibroBiologics closes $3M private placement with warrants By Investing.com - Investing.com South Africa
FibroBiologics Raises $3.0 Million in Private Placement; Issues Pre-Funded and Common Warrants - TradingView
FibroBiologics (FBLG) closes $3M placement with $6M warrant upside - Stock Titan
FibroBiologics Announces Closing of up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - STLtoday.com
FibroBiologics, Inc. announced that it has received $3 million in funding - marketscreener.com
Press Release: FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - 富途牛牛
Enterprise value to revenue forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Price to book forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Price to earnings forward of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Enterprise value to EBIT forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Enterprise value to revenue forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Number of shareholders of FibroBiologics, Inc. – NASDAQ:FBLG - TradingView
Enterprise value to EBITDA forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
Price to sales forward of FibroBiologics, Inc. – FWB:SG00 - TradingView
FibroBiologics, Inc. Actuals & Estimates (NASDAQ:FBLG) - TradingView
FibroBiologics raises $3M in private placement offering By Investing.com - Investing.com Australia
FibroBiologics (FBLG) Prices $9M Private Placement with Warrants - GuruFocus
FibroBiologics, Inc. Actuals & Estimates (LS:A426UV) - TradingView
FibroBiologics (FBLG) Secures $3M Through Private Placement Offe - GuruFocus
FibroBiologics raises $3M in private placement offering - Investing.com
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - STLtoday.com
FBLG Forecast — Price Target — Prediction for 2027 - TradingView
SG00 Forecast — Price Target — Prediction for 2027 - TradingView
A426UV Forecast — Price Target — Prediction for 2027 - TradingView
FibroBiologics, Inc. announced that it expects to receive $3 million in funding - marketscreener.com
Form 8K Fibrobiologics Inc For: 23 June By Investing.com - Investing.com India
FibroBiologics, Inc. Adopts 2026 Equity and Incentive Compensation Plan – Key Terms, Stock Option Agreement & SEC Filing Overview – Minichart - Minichart
Form 4 Fibrobiologics Inc For: 23 June By Investing.com - Investing.com Nigeria
Form 8K Fibrobiologics Inc For: 23 June - Investing.com UK
Director at FibroBiologics (FBLG) receives stock options for 30,803 shares - Stock Titan
FibroBiologics (FBLG) director receives grant of 30,803 stock options at $0.7503 - Stock Titan
30,803 options granted to FibroBiologics (FBLG) director Olivia - Stock Titan
FibroBiologics stockholders approve new equity and incentive compensation plan By Investing.com - Investing.com Nigeria
FibroBiologics stockholders approve new equity and incentive compensation plan - Investing.com
[8-K] FibroBiologics, Inc. Reports Material Event - Stock Titan
Fibrobiologics, Inc. Announces Non Standing for Re-Election of Stacy Coen to the Board - marketscreener.com
FibroBiologics (FBLG) AGM 2026 Summary - Quartr
FibroBiologics | 4: Statement of changes in beneficial ownership of securities-Director Niklas Victoria Ninon Olivia - Moomoo
FBLG: All proposals passed, board changes noted, and Nasdaq compliance risks discussed - TradingView
FibroBiologics receives patent allowance for wound therapy - Investing.com UK
1.17%
2.48%
大文字化:
|
ボリューム (24 時間):